<DOC>
	<DOCNO>NCT02969759</DOCNO>
	<brief_summary>INTRODUCTION : Amyotrophic Lateral Sclerosis ( ALS ) degenerative disease motor neurones brain spinal cord . The pathophysiological mechanism disease remain unknown . The average age onset ALS 60 year old , mean survival patient 2 year . The disease responsible progressive paralysis lead death respiratory failure . The treatment available Riluzole , modest efficiency progression disease . ALS third neurodegenerative disease , affect 6000 person France , 150 000 world . Among protagonist involve occurrence disease , mitochondrial perturbation protein accumulation seem central element . OBJECTIVES : To precise implication energy protein metabolism sporadic form ALS , identify potential biomarkers disease test new therapy . METHODS : The investigator study cell growth , bioenergetics , mitochondrial dynamic , free-radicals production , presence cytoplasmic inclusion , cytoskeleton structure stress response primary skin fibroblast obtain sporadic ALS patient . The study conduct period three year 3 centre specialize respectively motor neuron disease , mitochondrial metabolism neuronal cytoskeleton . PROSPECTS : If investigator achieve identify difference ALS fibroblasts control , result key element reinforce hypothesis systemic disease important metabolic participation , good define ALS pathophysiological mechanism , find potential biomarkers test new therapy .</brief_summary>
	<brief_title>Bioenergetics Protein Metabolism Sporadic Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>The investigator study fibroblast derive sporadic ALS patient . Clinical parameter collect sex , age , age onset , clinical presentation , electrophysiological respiratory parameter , treatment . Patients control derived fibroblast amplify cultivated skin biopsy . Primary fibroblast cell culture derive skin biopsy obtain control subject patient obtain write consent . Amplifications perform , passage 1 6 , allow time cell cryopreservation 10 sample per cell line . All experiment conduct cell similar passage number , range 6 25 , avoid artefact due senescence . Cell growth line monitor IncuCyte ZOOMÂ® system ( Essen Biosciences ) , microscope gantry resides cell incubator , network external controller hard drive gather process image data . Cell growth automatically calculate time point use relative cell density ( ratio occupy area total area acquire region ) . The respiratory parameter fibroblast monitor precisely high resolution oxygraph ( OROBOROS ) . Enzymatic activity complex mitochondrial respiratory chain measure spectrometry , mitochondrial membrane potential study fluorescence microscopy ( TMRM probe ) . The investigator also study mitochondrial dynamic architecture mitochondrial network fluorescence microscopy super-resolution microscopy ( SRM , Roper ) . The production free radical estimate probe sensitive oxidative stress . Finally , metabolomic study ( mass spectrometry QTRAP LC/MS/MS 5500 ABSciex ) perform characterise precisely metabolites cell assess metabolic profile . The investigator search protein inclusion ( intermediate filament , TDP43 , FUS , ubiquitin ) immuno-fluorescence technics . Western Blots perform study protein metabolism . The architecture cytoskeleton analyse SRM fluorescence microscopy , investigator try transfect fibroblast order express Neurofilaments study consequence cytoskeleton protein metabolism . The investigator study response cell stress ( hypoxia SCI-tive Dual , starvation ) , senescence ( high passage number ) .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Inclusion criterion : free sign write consent age 18 80 year old ALS define El Escorial Criteria normal neurological examination Exclusion criterion : comorbidity treatment susceptible impact metabolism differential diagnosis suspect , early late form ( &lt; 6 month &gt; 3 year ) ALS define El Escorial Criteria withdrawal consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bioenergetics</keyword>
	<keyword>Protein Metabolism</keyword>
	<keyword>Sporadic Amyotrophic Lateral Sclerosis</keyword>
</DOC>